ESC 365 - New VHD guidelines – What are the implications for the cardiologist?

Open Access

New VHD guidelines – What are the implications for the cardiologist?

Session: How the new European valvular heart disease guidelines could change the treatment of AS patients?

Topic: Aortic valve disease

Speaker: Professor H. Moellmann (Dortmund, DE)

Sponsored by Edwards Lifesciences

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Helge Moellmann

St. Johannes-Hospital, Dortmund (Germany)

13 presentations

0 follower

3 more presentations in this session

What is the evidence supporting the new valvular heart disease (VHD) guidelines regarding severe aortic stenosis (AS) treatment?

Speaker: Professor H. Moellmann (Dortmund, DE)

New VHD guidelines – What are the implications for transcatheter aortic valve implantation (TAVI) implanters?

Speaker: Professor H. Moellmann (Dortmund, DE)

Summary: key learnings and conclusion - How the new European VHD guidelines could change the treatment of AS patients?

Speaker: Professor H. Moellmann (Dortmund, DE)

Access the full session

How the new European valvular heart disease guidelines could change the treatment of AS patients?

Speakers: Professor H. Moellmann, Professor H. Moellmann, Professor H. Moellmann, Professor H. Moellmann

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources